Humira vs Ocrevus
Side-by-side drug price comparison from Medicare Part D data
Verdict
Humira costs 86% less per claim than Ocrevus ($3414.00 vs $23635.00). Humira has a generic alternative available. Total Medicare spending: Humira at $6.5B vs Ocrevus at $3.5B.
| Metric | Humira | Ocrevus |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $3,414* | $23,635 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $6.5B | $3.5B |
| Total Claims | 1,890,000 | 148,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | -22.1%* | 16.5% |
| Generic Available | Yes | Yes |
| Condition | Autoimmune Diseases | Multiple Sclerosis |
| Total Beneficiaries | 195,000 | 62,000 |
Humira costs 86% less per claim than Ocrevus ($3414.00 vs $23635.00). Humira has a generic alternative available. Total Medicare spending: Humira at $6.5B vs Ocrevus at $3.5B.
Explore More
The side-by-side above pulls the CMS Medicare Part D Drug Spending data data for both entity A and entity B. What follows is the interpretation — which specific axes carry the most weight for entity A versus entity B, and which differences are large enough to influence a real decision.
Practical use of the comparison: read the data above, then drill into the individual entity A and entity B detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: CMS Medicare Part D Spending, 2026.